Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine
Clinical trial NCT01430442 · COMPLETED
Trial details
- NCT number
- NCT01430442
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2012-05-01
- Enrollment
- 1026
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.